Treatment of mechanical valve thrombosis during pregnancy

Clinical Cardiology

Volumn 30, Issue 6, 2007, Pages 271-276

  Choi, Calvin ^a   Midwall, Scott ^a   Chaille, Peter ^a   Conti, C R ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Anticoagulation; Mechanical valve thrombosis; Pregnancy; Thrombolysis

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; STREPTOKINASE; UROKINASE; WARFARIN;

ANTICOAGULATION; BLEEDING; BLOOD CLOT LYSIS; CONGENITAL MALFORMATION; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG SAFETY; FEMALE; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HUMAN; LOW DRUG DOSE; PRACTICE GUIDELINE; PREGNANCY; RECOMMENDED DRUG DOSE; REVIEW; THROMBECTOMY; THROMBOSIS; TREATMENT PLANNING;

ADULT; ANTICOAGULANTS; BLOOD TRANSFUSION; CESAREAN SECTION; FEMALE; FIBRINOLYTIC AGENTS; GESTATIONAL AGE; HEART VALVE PROSTHESIS; HEMATOMA; HEPARIN; HUMANS; LIVE BIRTH; PRACTICE GUIDELINES; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; RECOMBINANT PROTEINS; THROMBOEMBOLISM; TISSUE PLASMINOGEN ACTIVATOR; WARFARIN;

EID: 34250898588     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.20054     Document Type: Review

References (21)

1. Elkayam U, Bitar F. Valvular heart disease and pregnancy. Part II: prosthetic valves. J Am Coll Cardiol 2005;46(3):403-410
2. Montorsi P, Cavoretto D, Alimento M, Muratori M, Pepi M. Prosthetic mitral valve thrombosis: can fluoroscopy predict the efficacy of thrombolytic treatment? Circulation 2003;108(suppl 1):II79-II84
3. Hernandez-Vila E, Stainback RF, Angelini P. Krajcer Z. Thrombolytics and left-sided prosthetic valve thrombosis. Tex Heart Inst J 1998;25(2):130-135
4. Chambers J, Whaley A, Campbell S. Doppler echocardiography in massive left atrial thrombus before and after successful thrombolysis. Int J Cardiol 1988;18(3):427-432
5. Lengyel M, Fuster V, Keltai M, Roudaut R, Schulte HD, et al. Guidelines for management of left-sided prosthetic valve thrombosis: a role for thrombolytic therapy. J Am Coll Cardiol 1997;30(6):1521-1526
6. Roudaut R, Labbe T, Lorient-Roudaut MF, Gosse P, Baudet F, et al. Mechanical cardiac valve thrombosis. Is fibrinolyisis justified? Circulation 1992;86(suppl 5):II8-II15
7. Deviri E, Sareli P, Wisenbaugh T, Cronje SL. Obstruction of mechanical heart valve prostheses: clinical aspects and surgical management. J Am Coll Cardiol 1991;17(3):646-650
8. Koller PT, Arom KV. Thrombolytic therapy of left-sided prosthetic valve thrombosis. Chest 1995;108(6):1683-1689
9. Tong AT, Roudaut R, Ozkan M, Sagie A, Shahid MS, et al. Prosthetic Valve Thrombolysis-Role of Transesophageal Echocardiography (PRO-TEE) Registry Investigators. Transesophageal echocardiography improves risk assessment of thrombolysis of prosthetic valve thrombosis: results of the international PRO-TEE registry. J Am Coll Cardiol 2004;43(1):77-84
10. Caceres-Loriga FM, Perez-Lopez H, Santos-Gracia J, Morlans-Hernandez K. Prosthetic heart valve thrombosis: Pathogenesis, diagnosis and management. Int J Cardiol 2005;110(1):1-6
11. Stein PD, Alpert JS, Copeland J, Dalen JE, Goldman S, et al. Antithrombotic therapy in patients with mechanical and biological prosthertic heart valves. Chest 1995;108(suppl 4):371S-379S
12. Turpie A, Gent M, Laupacis A, Latour Y, Gunstensen J, et al. A comparison of aspirin with placebo in patients with warfarin after heart-valve replacement. N Engl J Med 1993;329:524-529
13. Salazar E, Izaguirre R, Verdejo J, Mutchinick O. Failure of adjusted doses of subcutaneous heparin to prevent thromboembolic phenomena in pregnant patients with mechanical cardiac valve prostheses. J Am Coll Cardiol 1996;27(7):1698-1703
14. Bates SM, Greer IA, Hirsh J, Ginsberg JS. Use of Antithrombotic agents during pregnancy: the seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(suppl 3):627s-644s
15. Bonow RO, Carabello B, DeLeaon AC Jr, Edmunds LH Jr, Fedderly BJ, et al. ACC/AHA guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on management of patients with valvular heart disease). J Am Coll Cardiol 1998;32:1486-1582
16. Elkayam U, Singh H, Irani A, Akhter MW. Anticoagulation in pregnant women with prosthetic heart valve. J Cardiovasc Pharmacol Ther 2004;9(2):107-115
17. Warkentin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS, et al. Heparin-induced thrombocytopenia in patients treatd with low-molecular-weight haparin or unfractionated heparin. N Engl J Med 1995;332:1330-1336
18. Pettila V, Leinonen P, Markkola A, Hiilesmaa V, Kaaja R. Postpartum bone mineral density in women treated for thromboprophylaxis with unfractionated heparin or LMW heparin. Thromb Haemost 2002;87(2):182-186
19. Forestier F, Daffos F, Capella-Pavlovsky M. Low molecular weight heparin (PK 10169) does not cross the placenta during the second trimester of pregnancy: study by direct fetal blood sampling under ultrasound. Thromb Res 1984;34(6):557-560
20. Forestier F, Daffos F, Rainuat M, Toulemonde F. Low molecular weight heparin (CY 216) does not cross the placenta during the third trimester of pregnancy. Thromb Haemost 1987;57(2):234
21. Flessa HC, Klapstrom AB. Glueck MJ, Will JJ. Placental transport of heparin. Am J Obstet Gynecol 1965;93(4): 570-573